Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/2/21 17:49 | 11/1/21 | OYST | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | NJ | O | CFO | M.d | 99 | 11.51 | 0 | 9 | 17 | 58 | D | ||||||||||||||
10/22/21 16:41 | 10/21/21 | OYST | Health | BioPrd | Biological Products, (No Diag | Nau Jeffrey | NJ | DO | P,CEO | M.d | 51 | 1.02 | 0 | 50 | 81 | 112 | D | ||||||||||||||
10/20/21 16:38 | 10/18/21 | OYST | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | S | -8,161 | 14.84 | 0 | -550 | -14 | 3,246 | I | |||||||||||||||
10/20/21 16:32 | 10/18/21 | OYST | Health | BioPrd | Biological Products, (No Diag | Link William J Phd | NJ | D | S | -8,161 | 14.84 | 0 | -550 | -89 | 65 | I | |||||||||||||||
10/20/21 16:31 | 10/18/21 | OYST | Health | BioPrd | Biological Products, (No Diag | Ozawa Clare | NJ | DT | S | -8,161 | 14.84 | 0 | -550 | -14 | 3,256 | I | |||||||||||||||
9/7/21 08:03 | 9/2/21 | OYST | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | NJ | O | CFO | M.d | 86 | 11.51 | 0 | 8 | 18 | 50 | D | ||||||||||||||
9/1/21 18:00 | 9/1/21 | OYST | Health | BioPrd | Biological Products, (No Diag | Nau Jeffrey | NJ | DO | P,CEO | M.d | 10 | 1.02 | 0 | 10 | 19 | 62 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |